Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking-Reference-Cited by-同舟云学术

Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking

Published:2024-07-15 Issue: Volume: Page:
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

Qiu Genhong,Yu Li,Jia Lei,Cai Yanfei,Chen Yun,Jin Jian,Xu Lei,Zhu Jingyu^ORCID

Funder

Project Sponsored by the Scientific Research Foundation of Changzhou Vocational Institute of Engineering

Postgraduate Research & Practice Innovation Program of Jiangsu Province

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

University-Industry Cooperation Research Project in Jiangsu

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11030-024-10918-5.pdf

Reference72 articles.

1. Glassman CR, Tsutsumi N, Saxton RA, Lupardus PJ, Jude KM, Garcia KC (2022) Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation. Science 376(6589):163–169. https://doi.org/10.1126/science.abn8933

2. Clark JD, Flanagan ME, Telliez JB (2014) Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases. J Med Chem 57(12):5023–5038. https://doi.org/10.1021/jm401490p

3. Hu XY, Li J, Fu MR, Zhao X, Wang W (2021) The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Tar 6(1):402. https://doi.org/10.1038/s41392-021-00791-1

4. Ghoreschi K, Laurence A, O’Shea JJ (2009) Janus kinases in immune cell signaling. Immunol Rev 228:273–287. https://doi.org/10.1111/j.1600-065X.2008.00754.x

5. Villarino AV, Kanno Y, O’Shea JJ (2017) Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat Immunol 18(4):374–384. https://doi.org/10.1038/ni.3691